Statistics about Health, Pharma & Medtech in United States
Statistics
- Sorrento Therapeutics total assets 2018-2022
- Spero Therapeutics total assets 2019-2023
- Longeveron operating profit 2020-2023
- Spero Therapeutics total equity 2019-2023
- Stem Holdings, Inc. net cash 2019-2023
- Lineage Cell Therapeutics operating profit 2019-2023
- Stoke Therapeutics net cash 2019-2023
- Statera Biopharma, Inc. net cash 2013-2021
- Lucira Health gross profit 2020-2021
- Lineage Cell Therapeutics gross profit 2019-2023
- Longeveron gross profit 2020-2023
- Sorrento Therapeutics net cash 2018-2022
- Lucira Health revenue 2020-2021
- Sorrento Therapeutics total equity 2018-2022
- Lucira Health net cash 2020-2021
- Longeveron revenue 2020-2023
- Longeveron total equity 2019-2023
- Springworks Therapeutics total equity 2019-2023
- Maia Biotechnology net income 2021-2023
- Liquidia net income 2020-2023
- Springworks Therapeutics total assets 2019-2023
- Logicbio Therapeutics, Inc. net income 2017-2021
- Springworks Therapeutics net cash 2019-2023
- Lucira Health total equity 2019-2021
- Springworks Therapeutics liabilities 2019-2023
- Lineage Cell Therapeutics total equity 2019-2023
- Statera Biopharma, Inc. total equity 2017-2021
- Springworks Therapeutics operating profit 2019-2023
- Longeveron total assets 2020-2023
- Springworks Therapeutics revenue 2019-2023
- Lucira Health total assets 2020-2021
- Lineage Cell Therapeutics total assets 2019-2023
- Stoke Therapeutics total equity 2019-2023
- Longeveron net cash 2020-2023
- Stem Holdings, Inc. total equity 2019-2023
- Lineage Cell Therapeutics net cash 2019-2023
- Aadi Bioscience, Inc. operating profit 2019-2023
- Lineage Cell Therapeutics revenue 2019-2023
- Lumos Pharma total equity 2019-2023
- Aclarion, Inc. total equity 2020-2023
- Acorda Therapeutics total assets 2019-2023
- Acorda Therapeutics operating profit 2019-2023
- Acorda Therapeutics total equity 2019-2023
- Acorda Therapeutics net income 2019-2023
- Acorda Therapeutics net cash 2019-2023
- Aclarion, Inc. net cash 2021-2023
- Acorda Therapeutics revenue 2019-2023
- Aclarion, Inc. total assets 2021-2023
- Aclarion, Inc. gross profit 2021-2023
- Aclaris Therapeutics liabilities 2019-2023
- Statera Biopharma, Inc. liabilities 2017-2021
- Aclarion, Inc. operating profit 2021-2023
- Aclarion, Inc. liabilities 2021-2023
- Aclarion, Inc. revenue 2021-2023
- Sorrento Therapeutics liabilities 2018-2022
- Aclarion, Inc. net income 2021-2023
- Spero Therapeutics liabilities 2019-2023
- Lexicon Pharmaceuticals total equity 2019-2023
- Lantern Pharma total equity 2019-2023
- Stem Holdings, Inc. liabilities 2019-2023
- Aclaris Therapeutics revenue 2019-2023
- Spero Therapeutics net cash 2019-2023
- Longeveron net income 2020-2021
- Aadi Bioscience, Inc. net cash 2019-2023
- Aadi Bioscience, Inc. revenue 2019-2023
- Aadi Bioscience, Inc. liabilities 2019-2023
- Aadi Bioscience, Inc. total equity 2019-2023
- Aadi Bioscience, Inc. total assets 2019-2023
- Acurx Pharmaceuticals net income 2020-2023
- Aclaris Therapeutics total equity 2019-2023
- Lineage Cell Therapeutics net income 2019-2023
- Aclaris Therapeutics net cash 2019-2023
- Acurx Pharmaceuticals liabilities 2020-2023
- Acurx Pharmaceuticals total equity 2020-2023
- Aclaris Therapeutics total assets 2019-2023
- Lucira Health net income 2020-2021
- Aclaris Therapeutics operating profit 2019-2023
- Acurx Pharmaceuticals total assets 2020-2023
- Aclaris Therapeutics gross profit 2017-2018
- Stoke Therapeutics liabilities 2019-2023
- Aclaris Therapeutics net income 2019-2023
- Acurx Pharmaceuticals net cash 2020-2023
- Spyre Therapeutics, Inc. operating profit 2019-2023
- Greater Cannabis Company total assets 2019-2023
- International Stem Cell total assets 2019-2023
- Humacyte, Inc. net cash 2020-2023
- Progyny total equity 2019-2023
- Fulcrum Therapeutics total assets 2019-2023
- Fulcrum Therapeutics operating profit 2019-2023
- Fulcrum Therapeutics total equity 2019-2023
- Fulcrum Therapeutics net cash 2019-2023
- Fulcrum Therapeutics revenue 2020-2023
- Fulcrum Therapeutics net income 2019-2023
- Shuttle Pharmaceuticals Holdin total assets 2021-2023
- Greater Cannabis Company revenue 2018-2021
- Pure Harvest Corporate Group total equity 2016-2020
- Greater Cannabis Company liabilities 2019-2023
- Greater Cannabis Company total equity 2019-2023
- Harmony Biosciences Holdings net cash 2019-2023
- Histogen net cash 2018-2022